Jersey Shore University Medical Center, part of Meridian CardioVascular Network, was the first hospital in New Jersey to implant the Micra® Transcatheter Pacing System (TPS) – the world’s smallest pacemaker – since the device gained U.S. Food and Drug Administration (FDA) approval in April 2016.
Micra TPS is a new type of heart device that treats patients with bradycardia, a common heart condition characterized by a slow or irregular heart rhythm. At fewer than 60 beats per minute, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells.
At one-tenth the size of a traditional pacemaker, Micra TPS is the only leadless pacemaker approved for use in the U.S. The minimally-invasive procedure takes less than an hour, and unlike traditional pacemakers – is not visible.
Comparable in size to a large vitamin, the device does not require cardiac wires (leads) or a surgical “pocket” under the skin to deliver a pacing therapy. Instead, the device is small enough to be delivered through a catheter and implanted directly into the heart with small tines, providing a safe alternative to conventional pacemakers. It also automatically adjusts pacing therapy based on a patient’s activity levels. For patients who need more than one heart device, the device has a unique feature that enables it to be permanently turned off so it can remain in the body and a new device can be implanted without risk of electrical interaction.
Unlike traditional pacemakers, the Micra® Transcatheter Pacing System (TPS) is a miniaturized, fully self-contained pacemaker that delivers the most advanced pacing technology available to patients via a minimally invasive approach.
Meridian CardioVascular Network is anchored by physicians at the region's leading academic medical center, Jersey Shore University Medical Center. Jersey Shore is the only hospital in Monmouth and Ocean counties with an expert cardiac surgery program which performs more than 850 heart surgeries a year including: valve, bypass and aortic replacement.
Leading community hospitals for heart and vascular care in the network include Bayshore Community Hospital, Raritan Bay Medical Center-Old Bridge, Raritan Bay Medical Center-Perth Amboy, Riverview Medical Center, Ocean Medical Center, and Southern Ocean Medical Center. Meridian CardioVascular Network provides everything to diagnose, treat, and mend virtually all heart and vascular conditions, and the network's specialists are continuously among the first to provide remarkable treatment and surgical options.
To learn more about this new procedure and if it’s right for you, find a specialist in the Meridian CardioVascular Network online by using our Physician Directory, or call 1-800-DOCTORS.
AngioScreen® is a revolutionary, new heart and vascular health screening being offered by Meridian Health. In 15 minutes, this simple, non-invasive screening will provide you with information about your risk for heart disease and stroke.Learn More